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Abstract 
Since 2008, the emergent virus OsHV‑1µvar has provoked massive mortality events in Crassostrea gigas spat and juve‑
niles in France. Since 2012, mortality driven by the pathogenic bacteria Vibrio aestuarianus has stricken market‑sized 
adults. A hypothesis to explain the sudden increase in mortality observed in France since 2012 is that selective pres‑
sure due to recurrent viral infections could have led to a higher susceptibility of adults to Vibrio infection. In our study, 
two OsHV‑1‑resistant lines (AS and BS) and their respective controls (AC and BC) were experimentally challenged in 
the laboratory to determine their level of susceptibility to V. aestuarianus infection. At the juvenile stage, the selected 
lines exhibited lower mortality (14 and 33%) than the control lines (71 and 80%), suggesting dual‑resistance to OsHV‑1 
and V. aestuarianus in C. gigas. Interestingly, this pattern was not observed at the adult stage, where higher mortality 
was detected for AS (68%) and BC (62%) than AC (39%) and BS (49%). These results were confirmed by the analysis of 
the expression of 31 immune‑related genes in unchallenged oysters. Differential gene expression discriminated oys‑
ters according to their susceptibility to infection at both the juvenile and adult stages, suggesting that resistance to V. 
aestuarianus infection resulted in complex interactions between the genotype, stage of development and immunity 
status. Finally, survivors of the V. aestuarianus challenge at the juvenile stage still exhibited significant mortality at the 
adult stage during a second and third V. aestuarianus challenge, indicating that these survivors were not genetically 
resistant.
© 2015 Azéma et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
The French oyster industry has regularly suffered from 
massive mortality episodes (Figure 1). In the early 1970s, 
the production of the Portuguese oyster Crassostrea 
angulata collapsed due to massive mortality related to 
an iridovirus [1], and the production of the flat oyster 
Ostrea edulis was significantly reduced due to two para-
sites (Martelia refringens and Bonamia ostreae) [2]. Once 
a disease affecting an oyster species has been introduced 
or detected in an area, resources to minimize its effect on 
oyster populations or production are very constrained. 
Neither large-scale drug use nor vaccination (because 
invertebrates have no acquired immunity) is possible in 
open marine areas due to the scale of the environment, 
and seawater or other organisms can easily convey patho-
gens from the reservoir to naïve stocks, thereby favoring 
the transmission of a disease. In this context, two main 
solutions have been proposed to sustain French oyster 
production: (1) develop a selective breeding program to 
enhance disease resistance using the genetic resources 
available in oyster populations, and more radically (2) 
introduce another species that is not sensitive to the dis-
ease. This second step was taken in France during the 
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1970s with the massive introduction of Crassostrea gigas 
from Japan and British Columbia to replace C. angulata 
during the RESOR operation (Figure 1) [3]. However, the 
introduction of new species is not recommended because 
it can lead to the introduction of new diseases in local 
populations [4], competition for habitats and resources, 
new invasive species and other constraints (regulatory 
rules, preliminary studies and biological barriers).
French oyster production of C. gigas has ranged 
from 100 000 to 150 000 tons for several decades, but 
has unfortunately begun to decrease due to two dis-
eases (Figure  1). Indeed, massive mortality events have 
occurred every year since 2008, with high mortality rates 
for spat and juveniles (over 70%). A particular OsHV-1 
genotype (µvar) that was first described during a period 
of C. gigas mortality in 2004–2005 in Normandy [5] has 
been ascribed to the mortality [6]. Moreover, signifi-
cant mortality has been observed in market-sized adults 
since 2012 [7–9], and C. gigas production is expected 
to decrease again (Figure 1). The main pathogenic agent 
found in the dying oysters harvested during these mor-
tality episodes belonged to the species Vibrio aestuari-
anus. Because it would not be reasonable to introduce 
another oyster species to replace C. gigas, the possibility 
of genetic selection for disease resistance might limit the 
impact of diseases on wild and cultivated oysters.
High mortality rates related to OsHV-1µvar have been 
observed in the field since 2008 [10], and it is prob-
able that viral pressure on wild and cultivated oyster 
populations has been significant. Therefore, the emer-
gence of high mortality in adults has made it legitimate 
to investigate whether the selection provoked by viral 
infection has an impact on the susceptibility of adults 
to bacterial infections and whether there are correla-
tions or trade-offs between resistance to OsHV-1 and the 
expected resistance to V. aestuarianus. Consequently, it 
would be interesting to study whether the mass selection 
breeding program for C. gigas currently being managed 
at Ifremer [11] could enhance disease resistance to both 
OsHV-1 and V. aestuarianus.
Evidence of OsHV-1 resistance was demonstrated in 
spat C. gigas in 2009 using oysters selected based on their 
higher resistance to the summer mortality phenomenon 
in 2001 [12–14]. More recently, OsHV-1 resistance was 
found to be a highly heritable trait in C. gigas spat under 
field and laboratory conditions [11, 15]. However, experi-
mental selective breeding programs focused on V. aestu-
arianus resistance have not been described to date, and a 
relationship between resistance to OsHV-1 infection and 
V. aestuarianus infection has not been reported.
One hypothesis to explain disease resistance could be 
linked to host defenses, such as the immune capacity. 
Previous works identified markers for oyster survival 
capacity [16–19]. These studies led to the identification of 
a set of genes whose expression was either up-regulated 
in oysters able to survive virulent Vibrio infection [16, 
20] or differentially regulated in the hemocytes of oysters 
with a high capacity for survival [18].
Figure 1 French oyster production of C. angulata, C. gigas, and O. edulis since 1950. The main diseases that affected the production are 
indicated with red stars.
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The objective of this study was to investigate: (1) the 
resistance to V. aestuarianus infection in C. gigas at the 
juvenile and adult stages under laboratory-controlled 
conditions using two stocks of oysters and (2) to ana-
lyze the association of the survival capacity with the 
basal expression levels of a selection of immune-related 
genes. For each stock, a control line and a line selected 
for higher survival at the spat stage under field conditions 
(which was also related to higher resistance to OsHV-1 
infection) were evaluated. First, experimental OsHV-1 
infection was performed to confirm the level of resistance 
of each line to the viral infection. Then, two approaches 
were used to test for resistance to V. aestuarianus infec-
tion. The first approach challenged the oysters in primary 
exposures at the juvenile stage or the adult stage to deter-
mine the level of resistance according to the size and/
or age of the oysters. The second approach used succes-
sive infections at the adult stage with the survivors of the 
previous experimental infections to determine whether 
the survivors became resistant to the bacterial infection. 
Finally, we evaluated the immune status of non-stimu-




A mass selection to increase survival in C. gigas was 
performed in two stocks (named A and B) of wild oys-
ters sampled from two sites in the Marennes-Oléron 
Bay (Charente Maritime, France) in 2008. For each line, 
a base population G0 was produced in 2009, and a sub-
sample was kept in our facilities to avoid disease-related 
mortality and to produce the control line of the following 
generation (G1-C). This control allowed the assessment 
of the effects of changing environmental conditions dur-
ing the course of the experiment to estimate the response 
to selection [11]. The other sub-sample of oysters was 
deployed in the field, where mortality outbreaks caused 
by OsHV-1 were routinely observed each year since 2009 
[21]. Then, the survivors were spawned in 2010 to pro-
duce the selected line G1-S. The same approach was used 
in February 2011 and March 2012 to produce G2 and 
G3, respectively. Four sub-lines were produced for the 
selected line from G2; further details are given in [11].
The oysters used in this study were the control lines 
AC and BC of G3 and the selected lines AS and BS, which 
were the best sub-lines for survival and OsHV-1 resist-
ance in the field. The field evaluation of the C and S lines 
at the spat stage during the summer of 2012 confirmed 
a higher mortality for the C lines (92.9%) compared with 
the S lines (32.0%). Nevertheless, the oysters used in our 
experimental infections were either kept in our inland 
facilities to avoid disease-related mortality or deployed to 
the field in October 2012 prior to their evaluation in the 
laboratory (Figure 2).
Viral and bacterial suspensions
The viral suspension was obtained using the protocol of 
Schikorski [22]. Briefly, naïve and unselected hatchery-
produced oysters were infected by injecting 50 µL of a 
previous viral suspension after “anesthesia”. Dead oys-
ters were dissected; the mantle and gills were removed, 
pooled, diluted, crushed and filtered using a 0.22-µm fil-
ter to obtain a clarified tissue homogenate.
The Vibrio strain used in the bacterial challenges was 
the highly pathogenic strain 02/041 that was isolated 
during a mortality episode in adults. This strain was pre-
viously studied and was included in this study as a ref-
erence strain [23]. The Vibrio suspension was obtained 
from an isolate maintained at −80  °C. The bacterial 
strain was placed in liquid Zobell and incubated for 24 h 
at 20  °C with constant shaking at 20  rpm. The result-
ing solution was centrifuged at 3200 × g for 10 min. The 
supernatant was discarded, and the pellet was washed 
and suspended in sterile artificial sea water (SASW).
Mortality induction protocols
Two types of experimental infection protocols were used 
to evaluate disease resistance in C. gigas: a by-injection 
protocol and a by-cohabitation protocol. For all trials, the 
seawater was filtered, UV treated and maintained at 21 °C 
with adequate aeration and without the addition of food. 
For the large volume tanks (150 L), a recirculating system 
was used to optimize the horizontal transmission of the 
disease. The salinity ranged between 29.5 and 36.7% for 
all trials.
For the by-injection protocol, pathogenic agents were 
directly injected into the adductor muscles of oysters to 
test their disease resistance. First, oysters were “anes-
thetized” in a solution containing magnesium chloride 
(MgCl2, 50  g/L) in a mixture of seawater and distilled 
water (1:4, v:v) for 4 h. Subsequently, 50 µL of the infec-
tious solution (bacterial or viral suspension) was injected 
into the adductor muscle using a 1  mL micro-syringe 
equipped with an 18 g needle. The injected oysters were 
either naïve oysters of the selected or control lines or 
naïve unselected hatchery-produced oysters that were 
used as “sources” for the horizontal transmission of the 
disease to the selected and control lines through a by-
cohabitation protocol.
For the by-cohabitation components, we used the 
protocols previously described in [24, 25]. As described 
for the by-injection protocol, naïve and unselected 
hatchery-produced oysters were injected with a spe-
cific pathogen and then transferred into tanks for 
24 h. Then, they were placed in contact with the naïve 
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oysters of the selected and control lines to test their 
disease resistance. A ratio of 10  g of injected oysters 
(with the shell) per 10 L of sea water was used for all 
of the experiments. A dead oyster was defined as a 
moribund animal that was unable to close its valve after 
5 min out of the water.
Trial 1: experimental infection by cohabitation 
between oysters injected with OsHV‑1 and the selected 
and control lines
An experimental infection with OsHV-1 was performed 
in April 2013 to verify the higher resistance to OsHV-1 
infection of the selected lines AS and BS compared with 
the control lines AC and BC. The oysters were 13 months 
old, and the mean individual weight was 22 g (Table 1). 
The AS, BS, AC and BC lines were evaluated throughout 
the cohabitation with oysters injected with a viral sus-
pension as described above. For each line (AS, BS, AC 
and BC), four 5 L replicate tanks were used; each tank 
contained 10 oysters (Table 1). For three replicates, 4 oys-
ters injected with the viral suspension were added to each 
tank for 48 h. In the fourth tank, 4 oysters injected with 
SASW were added for 48 h. The mortality was recorded 
daily for 11 days.
Trial 2: experimental infection by injection of the selected 
and control lines with V. aestuarianus
The design of this trial consisted of intramuscular injec-
tion of the oysters with suspensions with different bac-
terial concentrations. The bacterial concentration was 
evaluated spectrometrically at 600 nm and adjusted to an 
optical density (OD) = 1; then, the suspension was seri-
ally diluted to obtain theoretical ODs of 0.0002, 0.002, 
0.02 and 0.2, corresponding to 104, 105, 106 and 107 bac-
teria per mL, respectively. The bacterial concentration 
and purity were verified by plating. Three 5 L tanks were 
used for each OD and each line; each tank contained ten 
oysters injected with 50 µL of V. aestuarianus (500 CFU 
at OD 104 and 0.5 million CFU at OD 107). For each line, 
an additional tank was used as a control; this tank con-
tained 10 oysters injected with SASW. Observations for 
mortality were performed daily for 6 days.
Figure 2 Summary of the production and exposure to V. aestuarianus by cohabitation challenges. Trials 3 and 4 were performed for the 
control and selected lines at either the juvenile or adult stages. Light grey boxes indicate primary‑challenge and dark grey boxes indicate a second 
and third exposure to the bacteria.
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Trial 3: primary infection by cohabitation between oysters 
injected with V. aestuarianus and the selected and control 
lines
Five sets of trials using a by-cohabitation protocol were 
used to better mimic natural infection. For each trial (with 
the exception of set 3), three 150 L tanks were used to chal-
lenge a larger number of larger animals at the same time. 
An additional tank was used for the controls, which con-
sisted of oysters intramuscularly injected with SASW and 
placed as sources in contact with the four lines (Table 1). 
In each tank, the oysters of the four lines were randomly 
placed together in the same tank with 25 oysters per line 
with the shells individually tagged for identification. For 
set 3 of trial 3, two 10 L tanks were used per line; each tank 
contained approximately 15–20 oysters (Table 1).
The five sets of trial used to evaluate the resistance of 
the four lines AS, AC, BS and BC to V. aestuarianus are 
summarized in Table 1 and Figure 2:
  • Three sets were performed in February and March 
2013. The naïve oysters were 11–13 months old and 
weighed 22  g (Table  1), which corresponded to the 
juvenile stage according to the oyster industry. All 
oysters were always kept in our facilities, and no 
mortality was recorded.
  • The fourth set was conducted during spring 2014. 
The oysters were 26  months old, and the mean 
individual weight was 120  g (Table  1), which corre-
sponded to the adult stage. The oysters were always 
kept in our facilities, and no mortality was recorded.
Table 1 Summary of the trials and sets to evaluate OsHV-1 and V. aestuarianus susceptibility.
For all trials, two unselected and control lines (AC and BC) and two lines selected for their higher resistance to OsHV-1 (AS and BS) were evaluated under controlled 
conditions
a Oysters used were survivors from field testing
b Oysters used were survivors from sets 1 to 3 of trial 3
c Oysters used were survivors from set 1 of trial 4
d One of the control line had 100% mortality before the trial
e Selected lines had at least 28 and 12 oysters in sets 4 and 5, respectively, whereas the control lines had less than 5 oysters
f The number indicated is without the control tanks
Trial 1 2 3 3 3 3 3 4 4
Set 1 2 3 4 5a 1b 2c


















Cohabitation Injection Cohabitation Cohabitation Cohabitation Cohabitation Cohabitation Cohabitation Cohabitation
Number of 
exposure
1st infection 1st infection 1st infection 1st infection 1st infection 1st infection 1st infection 2nd infection 3rd infection
Date of chal‑
lenge
Apr 2013 Jan 2013 Feb 2013 Mar 2013 Mar 2013 May 2014 Nov 2014 May 2014 Nov 2014
Age  
(months)
13 10 11 12 13 26 32 26 32
Individual 
weight (g)
22 22 22 22 22 120 100 100 170
Stage Juvenile Juvenile Juvenile Juvenile Juvenile Adult Adult Adult Adult
Number of 
tanksf
12 48 3 3 8 2 2 1 1
Tank volume 
(L)
5 5 150 150 10 150 150 150 150
Lines tank−1 1 1 4 4 1 4 4 4 3d
Oysters line‑1 
tank−1










No Yes Yes Yes Yes Yes Yes Yes Yes
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  • The fifth set was conducted during the fall of 2014 
with oysters kept for 2  years in the field at Agnas 
(Charente Maritime, France). The control and 
selected oyster lines experienced 70 and 34% mortal-
ity, respectively. The oysters were 32 months old, and 
the mean individual weight was 100 g.
Trial 4: successive infections by cohabitation of oysters 
injected with V. aestuarianus and the selected and control 
lines
All oysters that survived sets 1–3 in trial 3 were again 
challenged in trial 4 with two additional successive chal-
lenges in May 2014 and November 2014 (Figure  2). 
Between trial 3 and the first set in trial 4 and between the 
two sets of trial 4, the oysters were kept at the Ifremer 
facilities in La Tremblade. All effluent from the holding 
facilities was treated with chlorine. The occurrence of 
mortality was also recorded during these periods. In set 
1 of trial 4, the oysters were 26 months old with an aver-
age weight of 100 g, whereas in set 2 of trial 4 the oys-
ters were 32 months old with an average weight of 170 g 
(Table 1).
Detection of OsHV‑1 and V. aestuarianus DNA
For all of the trials, moribund oysters from the selected 
and control lines were sampled for the detection of 
OsHV-1 and V. aestuarianus DNA. Total DNA was 
extracted from tissue fragments (mantle + gills) using the 
QIAgen (Hilden, Germany) QIAamp tissue mini kit com-
bined with the QIAcube automated system according to 
the manufacturer’s protocol. The total DNA amount was 
adjusted to 5 ng/µL following Nanodrop (Thermo Scien-
tific) measurement.
A real-time PCR assay was conducted on the MX3000 
and MX3005 Thermocyclers (Agilent) using the Brilliant 
III Ultrafast kit (Stratagene). Each reaction was run in 
duplicate in a final volume of 20 µL containing the DNA 
sample (5 µL at a 5 ng/µL concentration), 200 nM of each 
primer (for OsHV-1, DPF 5′ ATT GAT GATGTG GAT 
AAT CTG TG 3′ and DPR 5′ GGT AAA TAC CAT TGG 
TCT TGTTCC 3′ [26] and for V. aestuarianus, DNAj-F 
5′ GTATGAAATTTTAACTGACCCACAA3′ and DNAj-
R 5′ CAATTTCTTTCGAACAACCAC 3′ [27]) and 
200 nM of an oligonucleotide probe (for V. aestuarianus 
DNAj, probe 5′ TGGTAGCGCAGACTTCGGCGAC). 
The real-time PCR cycling conditions were as follows: 
3 min at 95 °C, followed by 40 cycles of amplification at 
95 °C for 5 s and 60 °C for 20 s. For OsHV-1 DNA quan-
tification, melting curves were also plotted (55-95 °C) to 
ensure that a single PCR product was amplified for each 
set of primers. Negative controls (without DNA) were 
included.
Evaluation of the immune status of the selected 
and control lines
The immune statuses of the oyster lines were evalu-
ated based on the expression of immune-related genes 
in the AS, AC, BS and BC lines prior to trial 3 set 1 at 
12  months and trial 3 set 5 at 32  months. Immune-
related genes were selected based on previous studies 
showing their transcriptomic regulation following vibrio 
challenge or between oyster lines selected for their resist-
ance/sensitivity to in situ mortality [16, 18]. Oysters were 
removed from their shells, and the whole soft body was 
immediately plunged into liquid nitrogen. Then, the oys-
ters were pulverized in groups (three groups of 10 oys-
ters per oyster line) with a Mixer Mill MM 400 (Retsch) 
under liquid nitrogen conditions. The frozen oyster pow-
der was stored at −80  °C prior to RNA extraction for 
gene expression analysis.
RNA extraction from the frozen oyster powder was 
performed with the TRIzol Reagent (Invitrogen) accord-
ing to the manufacturer’s instructions. Briefly, 100 mg of 
oyster powder was homogenized in 1  mL of TRIzol by 
vortexing for 1  h at 4  °C. Next, the RNA samples were 
treated with 5  U of DNase I (Invitrogen) to eliminate 
DNA contamination according to the manufacturer’s 
instructions, followed by RNA precipitation to elimi-
nate the degraded DNA (with 100% isopropyl alcohol 
and 3 M Na-acetate). Then, the RNA samples were dis-
solved in 50 µL of RNase-free water and quantified using 
a NanoDrop spectrophotometer (Thermo Scientific). The 
integrity of the total RNA was verified using 1.5% aga-
rose gel electrophoresis. Finally, total RNA was reverse 
transcribed using the Moloney Murine Leukemia Virus 
Reverse Transcriptase (MMLV-RT) according to the 
manufacturer’s instructions (Invitrogen).
qPCR assays were performed on the Light-Cycler 480 
System (Roche) in a final volume of 5 µL containing 1× 
Light-Cycler 480 master mix, 0.5 μM of each primer and 
1 μL of cDNA diluted 1/8 in sterile ultra-pure water. 
The primer pairs used to amplify the 31 immune-related 
genes are listed in Table  2. Primer pair efficiencies (E) 
were calculated by five serial dilutions of pooled cDNA 
ranging from 1/2 to 1/64 in sterile ultra-pure water using 
the slopes provided by the LightCycler software accord-
ing to the equation: E =  10[−1/slope]. The qPCR program 
was composed of an initial denaturation step of 15 min at 
95  °C, followed by amplification of the target cDNA (35 
cycles of denaturation at 95 °C for 10 s, annealing at 57 °C 
for 20 s and extension at 72 °C for 25 s with fluorescence 
detection). Relative expression levels of the immune-
related genes were calculated with the method described 
by Pfaffl [28] and normalized using the mean of values of 
three constitutively expressed genes (Cg-EF1 [GenBank 
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AB122066], Cg-RPL40 [GenBank FP004478] and Cg-
RPS6 [GenBank HS119070]).
Statistical analyses
Survival was analyzed with the SAS 9 software using the 
GLIMMIX procedure by a logistic regression for bino-
mial data. The general model for the first trial was:
where Yi was the survival probability, µ was the inter-
cept, stocki represented stock A or line B, and selectionj 
represented the level of selection for OsHV-1 resistance 
(selected or control).




+ selectionj + stocki ∗ selectionj + ε
For trial 2, the bacterial concentration factor and all 
interactions between the bacterial concentrations, the 
stock and the selection factors were added to the model.
For the first three sets of challenges in trial 3, the set 
factor and its interactions were added to the model. A 
similar model was also used for the last two sets of chal-
lenges in trial 4.
For the gene expression analysis, statistical analysis 
was performed using the STATISTICA software version 
7.1 (StatSoft) using the Mann–Whitney U test (signifi-
cant value: p < 0.05). Hierarchical clustering of the gene 
expression data was performed with the Multiple Array-
Viewer software using the average linkage clustering with 
the Spearman Rank Correlation as the default distance 
metric.
Table 2 Primers and functional categories of the analyzed immune-related genes.
Gene number Functional category Name Sense primer AntiSense primer
72 Immune response Metallothionein a CAGCTCACACAGTCCCTTC CATGTACAGTTACACGATGC
122 Immune response Universal stress protein TTGAGGTTTCCGTGAACGAG AACAATCACCGGAACTGACG
130 Immune response Interferon‑induced protein 44 AAGATCCAACGATGAAAGAC TTGTCGACATCACTACAAAC
163 Immune response Big defensin TTCGCCTGCTTCCATACTGG GTCATGGTCACTCCTTATTC
189 Immune response C‑type lectin 2 like protein GTCATCTGACCACAATTACAG TCGATAGCAGCATTCCAGAG
220 Immune response MyD88 adaptor AGGTACCGGCTGTGATACGA TTCAAACGCCACCAAGACTG
234 Immune response Tumor necrosis factor ligand super‑
family
GGATACGCAAGAGGAACTGC TGGACATTAACGACACGCGC
293 Immune response Interleukin 17 ACTGAGGCTCGATGCAAGTG AGCCTTCTTGCTTCATGTGG
300 Immune response Heat shock protein 70 GCATGTGAGCGAGCAAAACG TGGCAGCTTGAACAGCAGC
303 Immune response Galectin ACGAAACGCTCTGATTGGTG TTAGTGGCATGGTAGGTCTG
304 Immune response L‑rhamnose‑binding lectin AGATGATTGTGAAAGCAGCGA ACTGTAGCGGTCATGCTCTG
306 Immune response Proline rich protein CACCATGTTCTCTCGGAGGA GTCTGCAATGTTAACCCTCAG
307 Immune response Hemocyte defensin GTTGTAGAGCGGGCTACTGTG CTTGGTCAGATTCAGACTGG
351 Immune response Metallothionein b GGAACTGTAGCTGTGGAGAC CCTTCTTACAGCAGCAGTCG
399 Immune response Metallothionein c ATGTCCGATCATTGTTCCTG ACAGGTTTCTGGTCCGTGAC
8 Cellular differentiation Angiopoietin‑1 receptor a TGACGTGCTCGGCAACATGC CATTGTGTCCCCGTGAAGCC
312 Cellular differentiation Angiopoietin‑1 receptor b CGAAATCGTCTTACGAACGC GTTAGCAAGATCCCGTTGAG
324 Cellular differentiation Early growth response protein CTACCTCCACAAGCGACATG ACGTCGTTACTATGTGAGGG
216 Cellular differentiation Placental protein 11 GCCAGATTTACCTGGAATGG ATGCGGTGTAGATAGCGATG
375 Cellular differentiation GTP‑binding protein Di‑Ras2 TTGGGCGTACAGTGACAACC TCTCTGTTTCCTCGTGAACC
396 Cytoskeleton reorganization Acyl‑CoA desaturase AGATGCAGACCCACACAACG GCGTTCCAAAGTGATTCTCC
401 Cytoskeleton reorganization Neurotrypsin AAACAATGCAAGGGAGAAGC CTATTGTCAGCACAATCTGG
441 Cytoskeleton reorganization Major vault protein TTCAAGAGTCAAGTGGATGC ACCATTGGCGGTATTGAAGG
439 Cytoskeleton reorganization Myosin essential light chain TACATAACGGGTCATGAGAC CAACACTGGATTACCACCTG
348 Cytoskeleton reorganization Calcineurin subunit B isoform 1 ACGGTGTATTCCTTGTGTCC TCTTCTGTACATGCAAGTGG
284 Cell adhesion‑communication Integrin beta‑PS CCCACCTAGTGCCAGTCAAG GAACTTTGACTTGTGTGACGT
420 Cell adhesion‑communication Hemagglutinin/amebocyte aggrega‑
tion factor precursor
TCGTGAATGCTGAACACACC TACACCTGTCCAAACCAAGG
283 Respiratory chain Extracellular superoxide dismutase AGAGGTGAATGCTACCAGG AGGCCAAGAATTCCGTCTG
422 Respiratory chain Glutathione transferase omega‑1 TTGGACAGGTTACCACACAG CAAACCAAGGCCATACCATG
378 Pro‑ and anti‑apoptosis Caspase 7 AGGGAGACAAGCGCCGTCAG TCCTCATTTGCTCTTCGTTC
166 No hit Unknown gene product 166 AAGTCGTATAGGAGCACAGG GGCTGAGAACATAATCCTCC
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Results
Trial 1: experimental infection by cohabitation 
between oysters injected with OsHV‑1 and the selected 
and control lines
No mortality occurred in the control tanks for each line 
(AC, AS, BC and BS). The first mortality occurred on 
day 2, and a peak of mortality was observed on day 5. As 
expected, the selected oysters presented low mortality (3 
and 7% for AS and BS, respectively), whereas the control 
oysters had significantly higher mortality (60 and 67% for 
AC and BC, respectively, p  <  0.001). The mean mortal-
ity was 32 and 37% for stocks A and B, respectively. The 
mortality between these stocks was not significantly dif-
ferent. Moreover, no difference was observed for the 
interaction between the stocks and the level of selec-
tion for resistance to OsHV-1 infection (p > 0.05). High 
amounts of OsHV-1 DNA was detected in all of the mor-
ibund oyster samples analyzed (n = 31).
Trial 2: experimental infection by injection of the selected 
and control lines with V. aestuarianus
No mortality was observed for oysters injected with 
SASW in the control tanks. The mortality rates of each 
line at each injected dose are shown in Figure  3. Very 
high mortality ranging from 77 to 100% was observed 
for all lines regardless of the infectious dose. None of the 
factors were significant with the exception of the bacte-
rial concentration factor (p  =  0.0003) and the interac-
tion between the stock and level of selection (p = 0.0005) 
(Table  3). At the stock level, the selected line exhibited 
lower mortality compared to the control line for stock 
B at each bacterial concentration; the opposite effect 
was observed for stock A at the two lowest concentra-
tions (Figure  3). The mortality at the lowest bacterial 
concentration was significantly lower compared to the 
morality at the other concentrations (p < 0.0001).
Trial 3: primary infection by cohabitation between oysters 
injected with V. aestuarianus and the selected and control 
lines at the juvenile and adult stages
Primary exposure with the V. aestuarianus cohabitation 
protocol at the juvenile stage (sets 1 to 3)
No mortality occurred in the control tanks of each set of 
trial 3. All moribund oysters sampled were positive for V. 
aestuarianus DNA (n =  45). The mortality of each line 
at the endpoint for the first three sets of trial 3 (corre-
sponding to the juvenile stage) is presented in Figure 4. 
In contrast to the by-injection protocol, higher vari-
ability in mortality was observed among the lines, with a 
range from 6 to 90%. A significant interaction was found 
between the sets and selection (p  =  0.0008) (Table  4); 
this interaction was explained at the selection level, with 
higher mortality observed in set 1 compared to set 3 for 
the selected lines and the highest mortality observed in 
Figure 3 Mean mortality (sd between tanks) in Trial 2. Oyster 
lines were challenged at the juvenile stage via intramuscular injection 
of V. aestuarianus for the control (AC and BC) and selected lines (AS 
and BS) at different bacterial concentrations.
Table 3 Logit analysis of mortality in Trial 2.
Oyster lines were challenged at the juvenile stage for primary infection by 
injection of V. aestuarianus for the control and selected lines of both stocks and 
at different doses
Effect DF F P
Stock 1 2.42 0.1207
Selection 1 0.6 0.4374
Bacterial concentration 3 6.29 0.0003
Stock × selection 1 12.23 0.0005
Stock × bacterial concentration 3 1.31 0.2708
Selection × bacterial concentration 3 0.5 0.6801
Stock × selection × bacterial concentration 3 2.06 0.1042
Figure 4 Mean mortality (sd between tanks) in Trial 3 sets 1 to 
3. Oyster lines were challenged at the juvenile stage via cohabitation 
challenges between oysters injected with V. aestuarianus and healthy 
juveniles of the control (AC and BC) and selected lines (AS and BS).
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the control lines in set 3 (Figure  4). The mean mortali-
ties of the three sets were 14 and 33% for the AS and BS 
lines, respectively; this mortality was significantly lower 
than the mortality observed for the control lines (71 and 
80% for AC and BC, respectively, p  <  0.0001) (Table  4). 
To a much lesser extent, stock A had significantly lower 
mortality (43%) than stock B (53%) (p = 0.0065).
Primary exposure with the V. aestuarianus cohabitation 
protocol at the adult stage (sets 4 and 5)
For the fourth set of trial 3, the mortality was 87, 45, 62 
and 70% for the AS, AC, BS and BC lines, respectively; 
the mortality decreased to 49, 32, 36 and 53%, respec-
tively, in the fifth set of challenges in trial 3 (Figure  5). 
None of the factors were significant with the exception of 
a significantly lower mortality in the fifth set compared to 
the fourth set (p =  0.0002) and a significant interaction 
between the stocks and level of selection (p  =  0.0012) 
(Table  5). At the stock level, the stock A control line 
had significantly lower mortality than the selected line, 
whereas the opposite trend was observed for stock B 
(Figure 5).
Expression levels of immune‑related genes can 
discriminate oyster lines in terms of susceptibility/
resistance to V. aestuarianus infection at the juvenile 
and adult stages
The hierarchical clustering of the 31 immune-related 
genes or only the differentially expressed genes 
(p  <  0.05) could separate the oyster lines in terms of 
their resistance/sensitivity to bacterial infection at the 
two developmental stages analyzed (12 and 32 months, 
Figure  6). At 12  months of age, hierarchical clustering 
of the gene expression data separated the oyster lines 
into two major clusters of conditions: the first cluster 
included the AS and BS lines, while the second cluster 
included the AC and BC lines (Figure 6A). At 32 months 
of age, two major clusters of conditions were found that 
were similar to those observed for the 12  month old 
oysters, but the oyster lines did not separate in the same 
manner (Figure  6B): the first cluster included the AC 
and BS lines, whereas the second cluster included the 
AS and BC lines. Interestingly, these discriminations of 
the oyster lines were in accordance with the resistance/
sensitivity to infection of the lines at 12 and 32 months 
of age.
In the juveniles, 11 genes showed differential gene 
expression patterns, while in the adults only 7 genes 
showed differential expression patterns. Among these 
differentially expressed genes, four genes were common 
to juveniles and adults (306, 283, 284 and 304). These 
four genes showed the same patterns of expression in the 
juveniles and adults according to their resistance/sensi-
tivity to infection. Thus, genes expressed at higher levels 
in the susceptible lines (AC and BC) vs. the resistant lines 
(AS and BS) in juveniles also appeared to be expressed 
at higher levels in the susceptible lines (AC and BS) vs. 
Table 4 Logit analysis of mortality in Trial 3 sets 1 to 3.
Oyster lines were challenged at the juvenile stage for a primary infection 
throughout 3 sets of cohabitation between oysters injected with V. aestuarianus 
and the control and selected lines of both stocks
Effect DF F P
Set 2 2.41 0.0909
Stock 1 7.46 0.0065
Selection 1 107.19 <.0001
Set × stock 2 0.43 0.6518
Set × selection 2 7.25 0.0008
Stock × selection 1 3.81 0.0515
Set × stock × selection 2 0.64 0.8576
Figure 5 Mean mortality (sd within l) in Trial 3 sets 4 and 5. Oys‑
ter lines were challenged at the juvenile stage for the three first sets 
of trial 3 and at the adult stage for sets 4 and 5 of trial 3 via cohabita‑
tion challenges between oysters injected with V. aestuarianus and 
healthy juveniles of the control (AC and BC) and selected lines (AS 
and BS).
Table 5 Logit analysis of mortality in Trial 3 set 4 and 5.
Oyster lines were challenged at the adult stage for a primary infection 
throughout 2 sets of cohabitations between oysters injected with V. aestuarianus 
and the control and selected lines of both stocks
Effect DF F P
Set 1 13.85 0.0002
Stock 1 0.00 0.9557
Selection 1 2.23 0.1368
Set × stock 1 0.40 0.5278
Set × selection 1 2.39 0.1233
Stock × selection 1 10.72 0.0012
Set × stock × selection 1 0.82 0.3648
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the resistant lines (AS and BC) in adults (genes 283, 284 
and 304). Likewise, the gene expressed at a higher level 
in the resistant lines (AS and BS) vs. the susceptible lines 
(AC and BC) in juveniles also appeared to be expressed 
at a higher level in the resistant lines (AS and BC) vs. the 
susceptible lines (AC and BS) in adults (gene 306). Other 
differentially expressed genes appeared to be associated 
with one developmental stage: 7 genes were found to be 
differentially expressed only in juveniles (216, 8, 420, 401, 
220, 396 and 441), and 3 genes were found to be differen-
tially expressed only in adults (189, 234 and 378).
Trial 4: successive infections by cohabitation 
between oysters injected with V. aestuarianus and the 
selected and control lines
After the three first sets of bacterial challenges of trial 3, 
the final mortality was 14, 71, 33 and 80% for AS, AC, BS 
and BC, respectively. During the period between trials 3 
and 4, the survivors were kept in a tank with filtered and 
UV-treated seawater enriched with microalgae. Although 
this period did not represent a disease challenge, the sur-
vivors still experienced significant mortality associated 
with the detection of V. aestuarianus DNA in the mori-
bund oysters. Most of the mortality was observed in July 
2013 after a spawning event. The mortality between trial 
3 and the first set of challenges of trial 4 was 74, 90, 32 
and 97% for AS, AC, BS and BC, respectively (Table 6); 
consequently, the cumulative mortality due to V. aestu-
arianus before trial 4 reached 78, 96, 54 and 99%, respec-
tively. Although the control lines were tested in trial 4, 
the remaining oysters numbered less than 5. Therefore, 
the mortality was not compared with the selected lines. 
During the first set of challenges in trial 4, the mortal-
ity was 46 and 28% for AS and BS, respectively (Table 5). 
No significant difference in mortality (<5%) was reported 
between the two sets of challenges in trial 4. Finally, the 
survivors exhibited some mortality, with 60 and 38% 
mortality for AS and BS, respectively (Table  6). The 
cumulative mortality after three successive challenges 
with V. aestuarianus in trials 3 and 4 (including the mor-
tality between trials) was 96, 99, 84 and 100% for AS, AC, 
BS and BC, respectively (Table 6).
Discussion
While mortality related to OsHV-1 and V. aestuarianus 
was reported in C. gigas in France prior to 2008 [27, 
29], their impact on French oyster production became 
predominant due to recurrent and intense mortality 
in spat and adult oysters. While selective breeding to 
enhance resistance to OsHV-1 infection in C. gigas has 
been recently demonstrated [11, 15], this demonstration 
is under investigation for V. aestuarianus. Nevertheless, 
this study aimed to elucidate whether selective pressure 
Figure 6 Discrimination of oyster lines contrasted in term of 
susceptibility based on the expression levels of immune-related 
genes. A Hierarchical clustering of the relative expression levels of 31 
immune‑related genes in non‑stimulated oysters of the AC, AS, BC and 
BS lines (three groups of ten oysters per line) at 12 months of age. B Hier‑
archical clustering of the relative expression levels of the 11 differentially 
expressed genes in non‑stimulated oysters of the AC, AS, BC and BS lines 
(three groups of ten oysters per line) at 12 months of age. C Hierarchical 
clustering of the relative expression levels of 31 immune‑related genes 
in non‑stimulated oysters of the AC, AS, BC and BS lines (three groups 
of ten oysters per line) at 32 months of age. D Hierarchical clustering of 
the relative expression levels of the 7 differentially expressed genes in 
non‑stimulated oysters of the AC, AS, BC and BS lines (three groups of 
ten oysters per line) at 32 months of age. The intensity of the color (from 
green to red) indicates the magnitude of differential expression (see color 
scale at the bottom of the image). The dendrogram at the left of the 
figures indicates the relationship among samples from the oyster lines, 
whereas the dendrogram at the top of the figures indicates the relation‑
ship among the relative expression levels of the selected genes.
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exerted by viral infections in the field could impact the 
susceptibility of C. gigas to bacterial infection.
In trial 1, the selected lines of both stocks exhibited 
much lower mortality (AS 3% and BS 7%) than the con-
trol lines (AC 60% and BC 67%). Although higher mortal-
ity was observed in the field evaluation (50 and 35% for 
AS and BS, respectively, and 91 and 94% for AC and BC, 
respectively [11]), our result was consistent with the field 
evaluation and supported that selection to enhance sur-
vival in C. gigas spat was effective for herpes virus infec-
tion. The lower mortality observed in our study could be 
explained by the use of larger (20 g versus <7 g) and older 
(13  months old versus  <5  months old) oysters (juvenile 
versus spat) because OsHV-1 resistance increased with 
age and size [21]. However, the most important informa-
tion from trial 1 was the confirmation that AS and BS had 
higher resistance to OsHV-1 infection than AC and BC 
before their evaluation of exposure to V. aestuarianus.
In trial 2, the mortality of three of the lines reached 
100%. The mortality for BS was  >90% at higher bacte-
rial concentrations corresponding to 5 × 104 and 5 × 105 
CFU per oyster (Figure  3). Although the mortality was 
slightly lower at the lowest bacterial concentration (cor-
responding to 500 CFU per oyster and ranging from 76 to 
96%; Figure 3), this finding confirmed that strain 02/041 
was a highly virulent strain in C. gigas juveniles (20  g); 
this finding was recently demonstrated in spat weigh-
ing 1.5 g that exhibited high mortality (>75%) at doses of 
102 and 107 CFU per spat [30]. Consequently, selective 
breeding to enhance higher resistance to OsHV-1 at the 
spat stage but does not confer higher resistance to V. aes-
tuarianus infection at the juvenile stage. Injection of the 
bacteria directly into the adductor muscle may bypass the 
oysters’ natural barriers to infection by V. aestuarianus. 
Due to the high mortality observed for all lines when 
the injection method is used, the cohabitation method 
should be applied to evaluate the resistance to V. aestu-
arianus infection of the control and the selected lines 
because transmission of the bacteria between oysters is 
what is expected to occur under natural conditions.
The three sets of trial 3 were performed at the juve-
nile stage, and all exhibited the same mortality patterns. 
The main finding revealed that the selected lines AS 
and BS had lower mortality than the control lines AC 
and BC (Figure  4). This result suggested that selection 
to increase survival at the spat stage in the field was also 
efficient in enhancing dual resistance to OsHV-1 infec-
tion and V. aestuarianus infection at the juvenile stage. 
A similar result was observed in Crassostrea virginica for 
dual resistance to Haplosporidium nelsoni and Perkinsus 
marinus [31], but most studies revealed that breeding 
for higher resistance to a disease did not confer a higher 
resistance to another disease [32].
Controversially, this pattern was not found at the 
adult stage, where much higher mortality was observed 
for both of the selected lines (particularly the AS line). 
Indeed, line AS exhibited 87% mortality in set 4 of trial 
3, whereas the control line AC had lower mortality (45%) 
(Figure  5). Additionally, while the AS line had higher 
mortality in adults than in juveniles, the AC line had 
lower mortality at the adult stage (45%) than at the spat 
stage (71%) (Figure  5). This same pattern was observed 
for BS and BC to a lesser extent, except that BS had lower 
mortality than BC at the adult stage (Figure 5). A similar 
pattern was observed in set 5 of trial 3, although the mor-
tality was lower than the mortality recorded in set 4 of 
trial 3. For set 5 of trial 3, it is important to note that the 
oysters were survivors of field mortality events that could 
have been related to OsHV-1 and/or V. aestuarianus 
and/or other pathogens. Consequently, the survivors 
used in set 5 were likely to be genetically more resist-
ant than the naïve oysters used in set 4, as demonstrated 
for the summer mortality phenomenon in C. gigas [33]. 
Another hypothesis could be related to the reproduc-
tive status. Sets 4 and 5 of trial 3 occurred in May and 
November of 2014, which represented the pre- and post-
spawning periods, respectively. Previous experiments 
have shown that the active gametogenesis period corre-
sponds to higher susceptibility to vibriosis in mollusks 
[34–37]. Consequently, primary infection of C. gigas 
with V. aestuarianus by cohabitation showed a different 
mortality pattern according to the stage of development 
and the level of selection. Hence, evaluation of vibriosis 
resistance in C. gigas represents a complex interaction 
between the genotype and the stage of development, 
and therefore the size, reproductive status and age of 
Table 6 Mortality rates per line during three successive 
challenges.
Cumulative mortality by cohabitation between oysters injected with V. 
aestuarianus and the control (AC and BC) and selected lines (AS and BS) are 
shown from sets 1, 2, and 3 of trial 3 and sets 1 and 2 of trial 4
In italics, the number of oysters was less than 5
AS AC BS BC
Initial number of oysters 160 153 165 155
Mean mortality of sets 1 to 3 of trial 3 (Feb to 
Mar 2013) (%)
14 71 33 80
Mortality between trial 3 and the first set of 
trial 4 (%)
74 90 32 97
First set of trial 4 in Mar 2014 (%) 46 40 28 100
Mortality between the two sets of trial 4 (%) <5 <5 <5 –
Second set of trial 4 in Nov 2014 (%) 60 0 38 –
Final oysters number remaining after three suc‑
cessive challenges
6 1 26 0
Cumulated mortality after three successive 
challenges (%)
96 99 84 100
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the oysters as described for OsHV-1 in C. gigas [21, 33, 
38]. Our study also revealed that selecting for resistance 
to OsHV-1 infection in spat did not confer either higher 
resistance or susceptibility to V. aestuarianus infection 
in adults, which was in agreement with similar studies 
in oyster species [39–41]. Experimental studies working 
on V. aestuarianus should replicate the oyster genotypes. 
The difference in mortality between the four lines used in 
our study also suggested a genetic basis for V. aestuari-
anus resistance in C. gigas, but this speculation required 
further investigation.
Our results showed high variability in the expression 
of selected immune-related genes that was dependent 
on the animal batch and age. This variability allowed the 
discrimination of oyster batches and correlated with their 
sensitivity to bacterial infection. Interestingly, expres-
sion of this set of immune-related genes was correlated 
with sensitivity to vibriosis rather than the genetic back-
ground. Because sensitivity to infection evolved depend-
ing on the oyster stage tested, the clustering of oyster 
batches also evolved in an age-dependent manner. At the 
juvenile stage, the lines selected for their resistance to 
OsHV-1 infection that presented low sensitivity to vibri-
osis were clearly discriminated from the control lines 
that presented higher sensitivity to V. aestuarianus infec-
tion. At the adult stage, selected line A and control line 
B showed intermediate sensitivity to vibriosis and were 
discriminated from control line A and selected line B 
with higher sensitivity to V. aestuarianus infection. Our 
results showed for the first time the possibility of using 
gene expression analysis to discriminate between oyster 
lines according to the resistance/susceptibility at two dif-
ferent developmental stages independent of the genetic 
background of the oyster lines. Specifically, four genes 
discriminated between the oyster lines according to their 
resistance/susceptibility.
These four genes are associated with different immune 
functions and suggest a complex discrimination of oyster 
lines through their immune status. The four genes able 
to discriminate oyster lines are related to antimicrobial 
functions (the proline rich peptide Cg-prp [42]), anti-oxi-
dative responses (the extracellular superoxide dismutase 
Cg-SOD [43]), cell adhesion (the Integrin beta-PS [44]) 
and recognition molecules (the L-rhamnose-binding lec-
tin [45]). These results show that it is now necessary to 
develop global transcriptomic approaches to clearly elu-
cidate the transcriptomic basis of the resistance/suscep-
tibility of oysters.
Finally, trial 4 was designed to test the effect of succes-
sive challenges using survivors of a previous challenge. 
The survivors of an initial exposure to V. aestuarianus still 
exhibited significant mortality in response to the same 
pathogenic agent at the second exposure. Consequently, 
the survivors were not genetically resistant, but they were 
either less susceptible during the previous exposures or 
the infection cohabitation did not allow equal expose of 
the oysters to the bacteria. Thus, a first contact with V. 
aestuarianus is not protective. This mortality pattern was 
also found in the abalone Haliotis tuberculata during two 
successive infections by the pathogen Vibrio harveyi [46]. 
Our result contrasted with the results obtained for the 
summer mortality phenomenon and OsHV-1, for which 
the survivors were selected for resistance and exhibited 
low mortality the following year [33, 38]. Between tri-
als 3 and 4, mortality due to V. aestuarianus was mostly 
observed after a spawning event, thereby reinforcing the 
importance of the reproductive status on the resistance 
to the bacteria. Post-spawning oysters were much more 
susceptible to the disease, as demonstrated with the mor-
tality event due to opportunistic Vibrio sp in C. gigas [34, 
37, 47] and OsHV-1 in C. gigas that occurred a couple 
of days after spawning [48]. Otherwise, the cumulative 
mortality after three successive exposures to V. aestuari-
anus was very high for all lines (ranging from 84 to 100%) 
(Table  6). These mortality rates are extremely concern-
ing for French oyster farmers, who cannot continue to 
remain feasible with this level of loss of C. gigas in their 
oyster stocks.
In conclusion, our study showed that: (1) cohabitation 
between injected oysters and healthy oysters seemed to 
be preferable for the genetic evaluation of V. aestuari-
anus resistance in C. gigas compared to intramuscular 
injection; (2) the mortality pattern for primary exposure 
to V. aestuarianus at the juvenile stage was similar to the 
pattern observed for OsHV-1 infection, with a higher 
resistance in selected oysters than control oysters, which 
suggested dual resistance at the juvenile stage; (3) dif-
ferences in the mortality patterns were highlighted 
between juveniles and adults during primary infection, 
suggesting a complex interaction between the genotype 
and the stage of development for Vibrio sensitivity; and 
(4) selection of immune-related genes allowed for the 
discrimination of batches depending on their sensitiv-
ity to infection at the two stages tested rather than on 
their genotype. The differences in mortality among the 
lines also suggested a genetic basis for the resistance to 
V. aestuarianus infection. Similarly, selection to enhance 
OsHV-1 resistance did not confer increased susceptibil-
ity or resistance to V. aestuarianus infection. Therefore, 
to improve resistance to V. aestuarianus infection, a 
breeding program needs to use high intensities of selec-
tive pressure. Resistance to V. aestuarianus infection 
should be evaluated through successive exposures to the 
disease because the oysters remained susceptible to V. 
aestuarianus even if they survived one or several mortal-
ity outbreaks related to the disease. Breeding companies 
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interested in enhancing Vibrio resistance should use 
oysters that were previously selected for resistance to 
OsHV-1 infection at the spat stage for broodstock. Then, 
these broodstocks should be evaluated at the adult stage 
to combine the resistance traits.
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